Subject to the terms of this Agreement, the Lead Party shall determine the appropriate regulatory strategy with respect to Co-Funding Products, in consultation with the Participating Party under the general direction and oversight of the JDC, JCC, and JSC. The Lead Party shall consult with the Participating Party in the preparation of regulatory strategies and with respect to all material regulatory actions, communications and Regulatory Filings for Co-Funding Products worldwide.

Coordination. Each Party shall ensure that its Affiliates and subcontractors promptly provide to such Party all information which such Party would be obligated to disclose to the other Party pursuant to this Section 6.2 if such information were otherwise developed by, or to come to the attention of, such Party.

Coordination. CRISPR and Vertex will, from time to time and at the request of the other Party, discuss the general information content relating to this Agreement that may be publicly disclosed; provided, however, that ​ will have no obligation to consult with ​ with respect to any scientific publication or public announcement concerning ​ Research, Development, Manufacture, Commercialization or use of any Product, except as otherwise expressly set forth in Section this ARTICLE 11.

Coordination. With regard to issues related to potential Biosimilar Applications referencing a Co-Funding Product, the Parties shall conduct and maintain ongoing and regular communications between their legal/intellectual property departments.

Coordination Obligations. Tenant acknowledges that Landlord shall continue to require access to the Building following Landlord’s delivery to Tenant of the Premises for the construction of the Tenant Improvements in order to complete Landlord’s Work and Tenant agrees to comply with the Site Logistics Instructions attached to this Work Letter as [Schedule 5]. “Tenant Improvement Work Readiness Condition” shall mean the point in the construction of Landlord’s Work when the elements described on [Schedule 6] have been achieved. When Tenant Improvement Work Readiness Condition has been achieved, Landlord shall notify Tenant in writing of the same and Deliver the Premises to Tenant Commencing on the Commencement Date, Landlord and Tenant shall work together in a cooperative manner, and shall likewise require each of their respective architects and engineers and contractors to work together in a cooperative manner, to coordinate the remaining Landlord’s Work and the Tenant Improvements and to achieve the substantial completion of all such work in as prompt and efficient manner as reasonably practicable. Landlord shall provide the anticipated schedule for the performance of Landlord’s Work within a reasonable period following the mutual execution and delivery of the Lease by the parties.

Coordination. The Parties shall coordinate in good faith through the IPC to segregate # claims within MTEM Collaboration Patents (excluding Optioned Product-Specific Patents) or Joint Collaboration Patents and # claims within BMS Collaboration Patents (including any Product-Platform Patent ​) or Optioned Product-Specific Patents into separate Patents (which may be related, e.g., as continuations or divisionals of one another). Such coordination shall include collaboration in the form of sharing pre-filing disclosure and planned filing dates, at least ​ in advance of filing, to ensure MTEM can file on a genus that has applicability to the ETB Platform beyond a particular Collaboration Target (or all Collaboration Targets if there are more than one at such time), or to ensure BMS can file, or request MTEM to file (prior to exercising its Option), on a species that claims subject matter that directly and specifically relates to # a Collaboration Target with respect to which BMS has exercised its Option or has an Option, # a Licensed Development Candidate directed to a Collaboration Target, or # ​. In addition, each Party shall promptly notify the other Party of the date the applicable patent filing was made. Without limiting the foregoing, if any proposed filing by BMS with respect to any BMS Collaboration Patent (including any Product-Platform Patent ​) or Optioned Product-Specific Patent discloses a species included within a genus disclosed or claimed by any Patent as to which MTEM has the right to prosecute under this [Section 8.2] ​, or if any proposed filing by MTEM with respect to any MTEM Collaboration Patent (excluding any Optioned Product-Specific Patent), ​, or Joint Collaboration Patents discloses a genus including a species disclosed or claimed by any Patent as to which BMS has the right to prosecute under this [Section 8.2] (​), then the Parties shall coordinate in good faith through the IPC the

Coordination. If upon termination of employment, Executive becomes entitled to rights under other plans, contracts or arrangements entered into by the Company, this Agreement shall be coordinated with such other arrangements so that Executive’s rights under this Agreement are not reduced, and that any payments under this Agreement offset the same types of payments otherwise provided under such other arrangements, but do not otherwise reduce any payments or benefits under such other arrangements to which Executive becomes entitled.

Coordination. Within 30 days of the Effective Date, [[Agenus:Organization]] shall provide electronic copies of the documents described in [Exhibit D] (the “[Exhibit D] Documents”) then in existence. Each Party shall appoint one (1) representative to act as a collaboration manager (each, a “Manager”) to coordinate activities of the Parties under this Agreement. The Parties shall meet at least once every six (6) months to engage in in dialogue on mutually agreed subjects, pursuant to an agenda to be circulated by the Managers at least ten (10) days prior to each such meeting. Coordination meetings shall be at such times and places as the Parties mutually agree, and may be conducted in person or telephonically. Agenda topics may include [[Organization A:Organization]]’s progress under the Development Plan, communications with Regulatory Authorities regarding the Licensed Products, discussion of Results, adverse events and other material matters relating to Clinical Trials, Publication opportunities and coordination of Commercialization efforts and [[Agenus:Organization]]’ progress on monotherapy development activities performed solely by or on behalf of [[Agenus:Organization]]. In advance of each such meeting, [[Organization A:Organization]] shall deliver an updated Development Plan to the [[Agenus:Organization]] Manager together with a written report regarding Development, Manufacturing and Commercialization activities in respect of Licensed Products since on the last such meeting. and [[Agenus:Organization]] shall deliver any updates on [[Agenus:Organization]]’ progress on monotherapy development activities performed solely by or on behalf of [[Agenus:Organization]] and updates to [Exhibit D] Documents or any [Exhibit D] Documents not previously provided.

Coordination. If upon termination of employment, Executive becomes entitled to rights under other plans, contracts or arrangements entered into by the Company, this Agreement shall be coordinated with such other arrangements so that Executive’s rights under this Agreement are not reduced, and that any payments under this Agreement offset the same types of payments otherwise provided under such other arrangements, but do not otherwise reduce any payments or benefits under such other arrangements to which Executive becomes entitled.

Coordination. The Parties will, from time to time and at the request of the other Party, discuss the general information content relating to this Agreement that may be publicly disclosed.